Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bonnefont JP, et al. The fasting test in paediatrics: application to the diagnosis of pathological hypo- and hyperketotic states. Eur J Pediatr. 1990;150(2):80–5.
Costa CC, et al. Dynamic changes of plasma acylcarnitine levels induced by fasting and sunflower oil challenge test in children. Pediatr Res. 1999;46(4):440–4.
van Veen MR, et al. Metabolic profiles in children during fasting. Pediatrics. 2011;127(4):e1021–7.
Chen YT, Cornblath M, Sidbury JB. Cornstarch therapy in type I glycogen-storage disease. N Engl J Med. 1984;310(3):171–5.
Chen YT, et al. Type I glycogen storage disease: nine years of management with cornstarch. Eur J Pediatr. 1993;152 Suppl 1:S56–9.
Rake JP, et al. Guidelines for management of glycogen storage disease type I – European Study on Glycogen Storage Disease Type I (ESGSD I). Eur J Pediatr. 2002;161 Suppl 1:S112–9.
Visser G, et al. Consensus guidelines for management of glycogen storage disease type 1b – European Study on Glycogen Storage Disease Type 1. Eur J Pediatr. 2002;161 Suppl 1:S120–3.
Rake JP, et al. Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I). Eur J Pediatr. 2002;161 Suppl 1:S20–34.
Chou JY, Jun HS, Mansfield BC. Glycogen storage disease type I and G6Pase-β deficiency: etiology and therapy. Nat Rev Endocrinol. 2010;6(12):676–88.
Boers SJ, et al. Liver transplantation in glycogen storage disease type I. Orphanet J Rare Dis. 2014;9:47.
Jun HS, et al. Molecular mechanisms of neutrophil dysfunction in glycogen storage disease type Ib. Blood. 2014;123(18):2843–53.
Lei KJ, et al. Genetic basis of glycogen storage disease type 1a: prevalent mutations at the glucose-6-phosphatase locus. Am J Hum Genet. 1995;57(4):766–71.
Chen YT, Van Hove JL. Renal involvement in type I glycogen storage disease. Adv Nephrol Necker Hosp. 1995;24:357–65.
Franco LM, et al. Hepatocellular carcinoma in glycogen storage disease type Ia: a case series. J Inherit Metab Dis. 2005;28(2):153–62.
Kishnani PS, et al. Glycogen storage disease type III diagnosis and management guidelines. Genet Med. 2010;12(7):446–63.
Slonim AE, Coleman RA, Moses WS. Myopathy and growth failure in debrancher enzyme deficiency: improvement with high-protein nocturnal enteral therapy. J Pediatr. 1984;105(6):906–11.
Demo E, et al. Glycogen storage disease type III-hepatocellular carcinoma a long-term complication? J Hepatol. 2007;46(3):492–8.
Shen JJ, Chen YT. Molecular characterization of glycogen storage disease type III. Curr Mol Med. 2002;2(2):167–75.
Bao Y, et al. Hepatic and neuromuscular forms of glycogen storage disease type IV caused by mutations in the same glycogen-branching enzyme gene. J Clin Invest. 1996;97(4):941–8.
McConkie-Rosell A, et al. Clinical and laboratory findings in four patients with the non-progressive hepatic form of type IV glycogen storage disease. J Inherit Metab Dis. 1996;19(1):51–8.
Lossos A, et al. Adult polyglucosan body disease in Ashkenazi Jewish patients carrying the Tyr329Ser mutation in the glycogen-branching enzyme gene. Ann Neurol. 1998;44(6):867–72.
Sokal EM, et al. Progressive cardiac failure following orthotopic liver transplantation for type IV glycogenosis. Eur J Pediatr. 1992;151(3):200–3.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Van Hove, J.L.K. (2015). Glycogen Storage Diseases. In: Bernstein, L., Rohr, F., Helm, J. (eds) Nutrition Management of Inherited Metabolic Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-14621-8_26
Download citation
DOI: https://doi.org/10.1007/978-3-319-14621-8_26
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-14620-1
Online ISBN: 978-3-319-14621-8
eBook Packages: MedicineMedicine (R0)